Skip to main content

Electrosurgery Market is expanding rapidly with Olympus launching ESG-150 electrosurgery generator for medical and surgical procedures

 


Electrosurgery is a very simple application of an extremely high-speed alternating current, often generated by ultrasound energy, to tissue. The term electrosurgery is sometimes used interchangeably with ultrasound surgery. The main advantages of this type of surgery are the ability to create very precise incisions with little blood loss; the ability to create a very uniform surface after surgery; and the ability to create scars that are virtually impossible to remove. When it comes to regional impact, North America seems to be exhibiting promising signs in the electrosurgery market. This is due to the fact that there is high geriatric population and the presence of robust and advanced healthcare infrastructure. On the contrary, Asia Pacific is registering significant traction with growing awareness related to electrosurgery and the presence of a large patient pool.

North America is expected to lead the global electrosurgery accessories market and this is attributed to the increasing patient population, growing demand for minimally invasive surgeries, and improvements in healthcare systems in the region. According to the American Society of Plastic Surgeons, in 2019, minimally invasive cosmetic procedures grew at a slightly higher rate than surgical procedures, and the total number of procedures increased for the third year in a row. 2019 marked the highest number of Botulinum toxin type A injections to date with over 7.69 million injections, and facial rejuvenation procedures are not showing signs of slowing down in 2020.

Increasing cases of gynecology surgery, cardiovascular surgery, general surgery, and others are augmenting the growth of the electrosurgery accessories market.  The rising number of ambulatory surgery centers around the globe is another key factor fostering the growth of the electrosurgery accessories market. For instance, in July 2020, Stryker launches an Ambulatory Surgery Center-focused business to meet the unique needs of this emerging customer. The center consists of unique products spanning more than 20 procedural specialties, and a wide range of flexible financing options.

 

Comments

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...